Extension Study for Long Term Evaluation of SAR153191 (REGN88) in Patients With Ankylosing Spondylitis

NCT01118728 · clinicaltrials.gov ↗

PHASE2

Phase

TERMINATED

Status

223

Enrollment

INDUSTRY

Sponsor class

Stopped Lack of benefit on efficacy

Conditions

Ankylosing Spondylitis

Interventions

DRUG: Sarilumab

Sponsor

Sanofi

Collaborators

[object Object]